Evidence map›Paper›PMID 26885077›Full record

ArticleInternational journal of clinical and experimental medicine2015

Risk factors associated with splenic hilar lymph node metastasis in patients with advanced gastric cancer in northwest China.

Zhenqiang Sun, Qisan Wang, Xianbo Yu, Chunlin Ou, Lizhong Yao, Kun Liu, Lin Liu, Lei Ge, Fa Fang, Zeliang Zhao and 1 more

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Exosomal circRNAs: Emerging Players in Tumor Metastasis.Frontiers in cell and developmental biology · 2021
    Review
  8. Reappraise role of No. 10 lymphadenectomy for proximal gastric cancer in the era of minimal invasive surgery during total gastrectomy: a pooled analysis of 4 prospective trial.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. TheJournal of Cancer · 2020
    Article
  15. Article
  16. Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Review
  17. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Zhenqiang SunDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital, Xinjiang Medical UniversityUrumqi 830011, China; Cancer Research Institute, Central South UniversityChangsha 410078, China.
Qisan WangDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital, Xinjiang Medical University Urumqi 830011, China.
Xianbo YuDepartment of Gynaecology, Cangzhou People's Hospital Cangzhou 061000, China.
Chunlin OuCancer Research Institute, Central South University Changsha 410078, China.
Lizhong YaoDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital, Xinjiang Medical University Urumqi 830011, China.
Kun LiuDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital, Xinjiang Medical University Urumqi 830011, China.
Lin LiuDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital, Xinjiang Medical University Urumqi 830011, China.
Lei GeDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital, Xinjiang Medical University Urumqi 830011, China.
Fa FangDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital, Xinjiang Medical University Urumqi 830011, China.
Zeliang ZhaoDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital, Xinjiang Medical University Urumqi 830011, China.
Haijiang WangDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital, Xinjiang Medical University Urumqi 830011, China.
Xinjiang Medical University · CNCentral South University · CNPeople's Hospital of Cangzhou · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are plenty of risk factors associated with splenic hilar lymph node metastasis (SHLNM) in patients with advanced gastric cancer (AGC). Whereas, their main influencing factors have not reached a consensus yet. The aim of the study is to investigate the related clinicopathological factors influencing SHLNM in AGC. A retrospective study was performed to investigate 150 patients who underwent D2 curative partial or total gastrectomy for gastric carcinoma from January 2007 to November 2012. Clinicopathological factors were analyzed by univariate and multivariate analysis. A total of 10.7% (16/150) of the patients had SHLNM. The overall ratio of metastatic lymph node (positive lymph nodes/lymph nodes harvested) in the splenic hilum was 17.5% (38/217). Univariate analysis results showed SHLNM was related with depth of invasion, tumor grade, tumor size, tumor location and Bormann type, with significant difference (P<0.05); Multivariate analysis demonstrated that SHLNM was related with depth of invasion and tumor size, with significant difference (P<0.05). Consequently, depth of invasion, tumor grade, tumor size, tumor location and Bormann type were associated with SHLNM in AGC, meanwhile depth of invasion and tumor size are independent risk factors. Preoperative predicting risk factors of SHLNM greatly benefits making more rational surgical scheme of treating AGC.

Indexed as

Advanced gastric cancermetastasisrisk factorsplenic hilar lymph node

Identifiers

PMID26885077
PMCPMC4723922
OpenAlexW2417493671

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.